Executive Panel – CMO Compliance in Focus: Data-Driven Insights and Best Practices for Sponsor Collaboration
Presented on Thursday, December 4, 2025
As the biopharma industry’s reliance on CMOs continues to expand across biologics, sterile injectables, and emerging modalities, both sponsors and contract manufacturers face increasing expectations for oversight, alignment, and data-driven quality management.
Download our webinar to hear directly from senior CMO executives shaping the future of quality and compliance across the global biopharma landscape, moderated by Michael de la Torre, CEO of Redica Systems. Together, they shared sponsor and CMO perspectives on the evolving state of quality, compliance, and collaboration in today’s complex outsourcing environment.
A few questions the panel explored:
- How have expectations of CMOs changed in recent years?
- What does “good oversight” look like from each side of the partnership?
- How can data transparency strengthen sponsor–CMO relationships?
- What innovations or mindset shifts will shape the next generation of CMO quality?
Get to know the speakers
Robin Kumoluyi
Global VP Quality, Regulatory Affairs and EH&S at Thermo Fisher Scientific, PSG
Dawn Carlson
VP, Global Compliance and Regulatory Affairs at Simtra
Helen Bickley
VP, Quality Operations at Fujifilm Diosynth Biotechnologies
Dr. Joerg Schnitzler
Corp. VP, Head of Global Quality BioPharma at Boehringer Ingelheim